Top 10 Companies in the Novel Peptide Synthesis Reagent Market (2026): Market Leaders Powering Global Innovation

MARKET INSIGHTS

Global novel peptide synthesis reagent market size was valued at USD 191.8 million in 2025 and is projected to reach USD 303.4 million by 2034, exhibiting a CAGR of 5.2% during the forecast period.

Novel peptide synthesis reagents are specialised chemical tools that enable the efficient creation of peptide chains, short sequences of amino acids linked by peptide bonds, used in drug discovery, diagnostics, and advanced biotechnology. These reagents include coupling agents, protecting groups, cleavage reagents, and activating compounds that facilitate solid‑phase peptide synthesis (SPPS) with enhanced efficiency, reduced by‑product generation, and improved compatibility with automated synthesis platforms.

The market is experiencing steady growth due to several factors, including rising demand for peptide‑based therapeutics, increased investment in biopharmaceutical research, and the transition from traditional benzotriazole‑based reagents to safer Oxyma‑based alternatives. Additionally, the expanding application of peptides in oncology, metabolic disorders, and vaccine development is driving reagent consumption. Initiatives by key players are also expected to fuel market growth. For instance, in October 2025, ProImmune Ltd announced the launch of its new ProVE SL Self‑Loading MHC Class I Monomers, offering researchers unprecedented flexibility with over 50 HLA alleles available. Merck KGaA, Thermo Fisher Scientific Inc., Bachem Holding AG, and GL Biochem are some of the key players that operate in the market with a wide range of portfolios.

Novel Peptide Synthesis Reagent Market – View in Detailed Research Report

PRODUCT DEFINITIONS

Peptide synthesis reagents encompass a range of chemical agents that facilitate the construction of peptide bonds during SPPS. They include coupling agents such as HATU, HBTU, and COMU; protecting groups like Boc and Fmoc; cleavage reagents such as TFA; activating compounds including Oxyma; and purification agents to remove by‑products. These reagents are critical for achieving high purity, yield, and reproducibility in peptide manufacturing.

TOP 10 COMPANIES IN THE NOVEL PEPTIDE SYNTHESIS REAGENT MARKET (2026)

🔟 1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Sigma‑Aldrich portfolio of coupling agents, protecting groups, and solid‑phase resins

Merck KGaA leverages its extensive R&D and global manufacturing to supply high‑quality reagents for peptide synthesis. Their products support both academic research and industrial pharmaceutical development, ensuring consistent batch‑to‑batch performance.

Sustainability & Growth Initiatives: Investment in green chemistry, reduction of hazardous waste, and development of recyclable solid supports.

• Development of Oxyma‑based coupling systems with lower toxicity.
• Expansion of automated synthesis support through new product lines.
• Commitment to ESG targets in manufacturing operations.

9️⃣ 2. Thermo Fisher Scientific Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: Comprehensive reagent suite for SPPS and peptide purification

Thermo Fisher provides a global distribution network and integrated solutions that combine reagents with instrumentation, enhancing user experience and reducing time‑to‑market for peptide therapeutics.

Sustainability & Growth Initiatives: Focus on reducing solvent usage and improving energy efficiency in production.

• Launch of water‑soluble coupling reagents.
• Partnerships with academic institutions for green chemistry research.
• Implementation of circular economy practices in packaging.

8️⃣ 3. Bachem Holding AG

Headquarters: Zofingen, Switzerland
Key Offering: Specialty amino acid derivatives and protection chemistry

Bachem’s expertise in small‑molecule and peptide synthesis reagents positions it as a key supplier for complex peptide projects, including antibody‑drug conjugates.

Sustainability & Growth Initiatives: Scale‑up of high‑purity manufacturing and reduction of hazardous waste.

• Development of microwave‑assisted synthesis platforms.
• Investment in renewable energy for production facilities.
• Collaboration with CDMOs to streamline supply chains.

7️⃣ 4. GL Biochem (Shanghai) Ltd.

Headquarters: Shanghai, China
Key Offering: Cost‑effective research‑grade reagents and GMP‑compliant solutions

GL Biochem serves the rapidly expanding Chinese and global markets with a focus on affordability and regulatory compliance.

Sustainability & Growth Initiatives: Adoption of green chemistry principles and local sourcing.

• Launch of recyclable resin lines.
• Partnerships with local universities for reagent development.
• Implementation of ISO 14001 environmental management.

6️⃣ 5. AAPPTec LLC

Headquarters: Wilmington, Delaware, USA
Key Offering: Proprietary Oxyma‑based activating reagents and microwave‑assisted synthesis kits

AAPPTec’s innovative chemistry reduces reaction times and enhances safety, making it attractive for high‑throughput laboratories.

Sustainability & Growth Initiatives: Focus on non‑explosive, low‑allergen reagents.

• Development of DIC/Oxyma systems for automated platforms.
• Collaboration with industry consortia on green chemistry standards.
• Expansion of global distribution through strategic partners.

5️⃣ 6. FluoroChem Ltd.

Headquarters: London, United Kingdom
Key Offering: Advanced protecting group chemistries and specialty reagents

FluoroChem supplies reagents that enable precise protection strategies, critical for complex peptide sequences.

Sustainability & Growth Initiatives: Development of recyclable reagents and reduction of hazardous by‑products.

• Launch of recyclable Fmoc‑protected resins.
• Partnerships with EU green chemistry initiatives.
• Investment in solvent‑free synthesis technologies.

4️⃣ 7. GenScript Biotech Corporation

Headquarters: Newark, California, USA
Key Offering: Comprehensive peptide synthesis reagent portfolio and custom synthesis services

GenScript combines reagent supply with end‑to‑end peptide production, supporting vaccine and therapeutic development.

Sustainability & Growth Initiatives: Focus on eco‑friendly reagents and process optimization.

• Development of water‑soluble coupling agents.
• Implementation of lean manufacturing processes.
• Collaboration with biotech startups for rapid peptide synthesis.

3️⃣ 8. ProImmune Ltd.

Headquarters: London, United Kingdom
Key Offering: MHC‑peptide complex reagents and immunology tools

ProImmune’s reagents enable precise immunological assays and vaccine research, expanding the application of peptide synthesis.

Sustainability & Growth Initiatives: Investment in sustainable reagent development.

• Launch of low‑toxicity MHC monomers.
• Partnerships with academic immunology centers.
• Adoption of green chemistry standards in production.

2️⃣ 9. Tokyo Chemical Industry Co., Ltd. (TCI)

Headquarters: Tokyo, Japan
Key Offering: Specialty reagents for peptide synthesis and organic chemistry

TCI supplies a broad range of reagents, supporting both research and industrial peptide manufacturing.

Sustainability & Growth Initiatives: Focus on eco‑friendly production and waste reduction.

• Development of recyclable solid supports.
• Implementation of energy‑efficient manufacturing.
• Collaboration with Japanese universities on green chemistry.

1️⃣ 10. IRIS Biotech GmbH

Headquarters: Berlin, Germany
Key Offering: Innovative peptide synthesis reagents and labeling technologies

IRIS Biotech provides reagents that enable advanced labeling and purification for peptide‑based diagnostics.

Sustainability & Growth Initiatives: Commitment to sustainable chemistry and process efficiency.

• Launch of biodegradable labeling reagents.
• Partnerships with EU research programs.
• Implementation of circular economy practices.

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/288331/global-novel-peptide-synthesis-reagent-forecast-market

Get Full Report: https://www.24chemicalresearch.com/reports/288331/global-novel-peptide-synthesis-reagent-forecast-market

Outlook to 2034

The global market for novel peptide synthesis reagents is projected to grow steadily, driven by expanding therapeutic pipelines, increasing demand for personalized medicine, and the adoption of green chemistry. By 2034, the market is expected to reach USD 303.4 million, with a CAGR of 5.2% from 2025 to 2034.

Future Trends

• Continued shift toward Oxyma‑based coupling systems for safety and efficiency.
• Integration of automated and continuous‑flow synthesis platforms.
• Growth of peptide conjugates and antibody‑drug conjugates requiring specialized reagents.
• Expansion of green chemistry initiatives, including recyclable resins and solvent‑free processes.
• Increasing focus on sustainability certifications and ESG compliance across the supply chain.
• Emergence of AI‑driven reagent design and process optimization.